Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
0.9294
-0.0489 (-5.00%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Alector Employees
Alector had 238 employees as of December 31, 2024. The number of employees decreased by 6 or -2.46% compared to the previous year.
Employees
238
Change (1Y)
-6
Growth (1Y)
-2.46%
Revenue / Employee
$422,513
Profits / Employee
-$500,206
Market Cap
91.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ALEC News
- 3 days ago - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease - GlobeNewsWire
- 22 days ago - Alector Provides Executive Leadership Update - GlobeNewsWire
- 7 weeks ago - Alector, Inc. (ALEC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 2 months ago - Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call - GlobeNewsWire
- 3 months ago - Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025 - GlobeNewsWire
- 4 months ago - Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalysts - Benzinga